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SUMMARY Two patients with features of multiple symmetric lipomatosis 
type 2 are presented. This particular disorder with a characteristic 
distribution of fat should be considered on differential diagnosis of 
obesity. Besides being rare, it may occasionally be unrecognized, 
especially in females. The etiology remains unknown; however, the 
association with high alcohol consumption is very strong. Several issues 
about the possible metabolic role of lipomatous adipose tissue have 
been discussed. Patients with multiple symmetric lipomatosis should be 
treated by liposuction or surgery instead of being submitted to diets.
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IntRodUCtIon
 A little more than a decade ago, the discovery 
of adipokines raised a new interest in adipose tis-
sue. It has been even admitted as a new endocrine 
organ. Changes in fat distribution among differ-
ent depots of adipose tissue have emerged as an 
origin of important disorders (1). Visceral adipose 
tissue accumulation has been considered to pro-
mote metabolic diseases like diabetes and athero-
sclerosis. The increase in subcutaneous adipose 
tissue mass is a cause of common esthetic con-
cerns; it has been widely extracted by liposuction, 
but also used as implant in other correction pro-
cedures. Finally, adipose tissue has been proven 
as a rich source of mesenchymal stem cells that 
can differentiate towards adipogenic, osteogenic, 
chondrogenic, myogenic and neurogenic lineages. 
Mesenchymal stem cells have been considered as 
the reserve for tissue maintenance and repair with 
the possible future huge clinical implications (2). 
 In times when an obesity epidemic has been 
overwhelming the contemporary health care, we 
present a specific disorder of fat accumulation, 
multiple symmetric lipomatosis (MSL). A deeper 
insight into this disease might also bring novel 
perspectives in the problem of obesity. Brodie was 
the first to observe MSL in 1848, but Madelung 
in 1888 and Launois Bensaude in 1889 described 
the disorder in series of cases, so it is usually re-
ferred to as Madelung disease or Launois Ben-
saude syndrome (3). MSL seems to occur more 
frequently in Mediterranean countries, although 
several cases described to date originated from 
different parts of the world (4). 
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 Two main forms of MSL are known. In type 1 
MSL, lipomatous tissue is accumulating around 
the neck, upper trunk and arms. This type occurs 
in men, patients are often underweight and unin-
volved subcutaneous tissue is usually reduced or 
even atrophic. Type 2 MSL affects both men and 
women. It is characterized by adipose tissue accu-
mulation in the upper back, deltoid regions, upper 
arms, hips and thigh regions. Similar to an exag-
gerated female fat distribution producing the so-
called pseudo-athletic appearance (3). We have 
chosen two different cases among our patients 
with type 2 MSL to describe the main characteris-
tics and discuss several issues in the field. 
CASe RepoRtS
 Case 1
 A 61-year-old woman was referred to plastic 
surgeon because of esthetic disfigurement. She 
noticed initial appearance of lipoma at the age of 
50 in the upper back region and it was surgically 
removed. However, in the last 3 years she noticed 
intensive enlargement of fatty deposits in her up-
per back but also on both arms and hips (Fig. 1). 
She claimed to have gained about 8 kg during that 
period. She entered her menopause at age 43. 
She smoked and admitted only moderate alcohol 
intake, however, her impaired liver function raised 
suspicion of that statement. In fact, elevated level 
of γ-glutamyltransferase (GGT) was the only ab-
normality revealed on laboratory testing.
 Her body weight was 81 kg, height 161 cm 
and body mass index (BMI) 31.5 kg/m2. Physical 
examination revealed no alterations other than li-
pomatous enlargements on her upper back and 
proximal limbs. The largest upper back lipoma as 
the most disfiguring one was surgically removed. 
Cytologic and additional histologic examination 
showed only normal adipose tissue.
 Case 2
 A 74-year-old woman was referred to our en-
docrinology outpatient clinic because of obesity. 
The characteristic pattern of lipomatosis fat dis-
tribution in this generally very obese woman was 
first revealed during blood pressure measurement 
by observing disproportionate fat accumulation 
between her arms and forearms. On direct ques-
tioning, she remembered that she had had several 
lipomas “large as eggs” surgically removed in the 
regions of posterior knees and elbows from the 
age of 50. Afterwards, she observed progressive 
thickening of both her arms and upper legs. Her 
menopause onset was at the age of 44 and her 
weight increased from that period by about 25 kg. 
She admitted having drinking a lot at her younger 
age. Her right hip was replaced because of osteo-
arthritis at age 64. For the last four years, she had 
been treated for arterial hypertension and supra-
ventricular arrhythmia.
 Her body weight was 101 kg and height 155 cm, 
yielding a BMI of 42 kg/m2. She had evident scars 
after lipoma excision on her elbows and knees. On 
palpation, her upper arms were almost completely 
occupied with diffuse fatty deposits and only some 
nodular fatty masses could be differentiated close 
to the right elbow. Diffuse lipomatous masses 
spread from her thighs to the upper third of her 
lower legs and ended with a relatively sharp limit. 
Besides that, she had a few prominent nodular 
Figure 1. Case No. 1: back view (A); side view (B).
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masses of 3 to 4 cm in diameter on the back of her 
knees. Laboratory testing revealed only a slight 
temporary increase in thyroid-stimulating hormone 
(TSH), with no other metabolic abnormalities. No 
therapeutic intervention for her lipomatous tissue 
was planned. 
 dISCUSSIon
 Patients with type 1 MSL present with specific 
fat collar and due to this striking appearance the di-
agnosis can usually be confirmed on the first sight. 
However, the cases of type 2 MSL described here 
show that occasionally the disease may not be so 
evident. It is now admitted that the diagnosis of 
MSL is confirmed by the presence of multiple non-
encapsulated lipomas, the recognition that these 
fat masses are symmetric and that there is persis-
tent uninvolvement of distal parts of the forearms 
and legs (3,5).  
 For instance, the largest contemporary series of 
patients with MSL were recruited in Italy. During 
the 1974-2000 period, some 60 males and only 
two female patients with MSL were identified. 
From that time on, in only two following years, 
nine more women with MSL were identified (3). 
All women reported up to now in that cohort and 
other literature reports had type 2 MSL, indicating 
that its clinical expression is sex related. In fact, 
the unawareness and peculiar clinical picture of 
the disease makes us also wonder whether type 
2 MSL may occasionally proceed unrecognized. 
The particular pathognomonic appearance may be 
concealed or become less evident when occurring 
together with simple obesity, especially in women. 
Our case 2 is instructing. In the beginning, the 
disorder was treated as simple lipomas and later, 
when prominent diffuse fat masses predominated, 
it was almost confused with simple morbid obesity. 
This could especially happen in elderly individuals 
with hanging lipomatous fatty deposits because of 
involution and loss of elasticity of the skin and sub-
cutaneous tissue. Cytologic examination would be 
the most practical tool for this differential diagnosis 
but no clear differences have yet been recognized 
between normal and lipomatous adipose tissue. 
 We can only emphasize that one of the key ele-
ments to suspect the diagnosis of lipomatosis is a 
history of lipoma occurrence several years before. 
The nodular aspect of lipomatous masses can only 
be observed at the disease onset. Subsequently, 
the lipomatous tissue spreads and occupies the 
arms and upper parts of the legs. The evolution 
varies greatly, but our patients confirm that in spite 
of operative treatment, lipomas have high ability to 
regenerate (5). This is also a common excuse why 
liposuction as the most appropriate treatment has 
not been usually offered to these patients.
 The etiology of lipomatosis has been related to 
defects in adrenergic stimulated lipolysis or prolif-
eration of the brown adipose tissue remnants (6). 
However, the latest investigations refer to the pos-
sible mitochondrial metabolism impairment that 
leads to triglyceride accumulation in adipocytes 
(7). Mitochondria are also very important for alco-
hol metabolism. Actually, higher alcohol consump-
tion was the most common trait in our and most 
other patients reported; therefore the postulated 
causal relationship is quite likely. Cases of MSL 
have also been described in patients with point 
mutations of mitochondrial DNA (7). 
 Weight gain in patients with lipomatosis is 
mostly attributable to the expansion of lipomatous 
tissue. From the practical point of view, most im-
portant is that diets should not be prescribed to li-
pomatosis patients because this tissue is not sen-
sitive to calorie restriction. Although it is currently 
admitted that both hypertrophic and hyperplastic 
expansion of adipocytes exists, it is considered 
that enhanced adipogenesis per se cannot be 
the cause of obesity (1). Adipogenesis in obesity 
is claimed to be only the result of imbalance be-
tween energy intake and output, i.e. the conse-
quence of excess calories. The accumulation of 
adipose tissue in lipomatosis could be an example 
of adipogenesis that is not calorie-dependent. The 
role of this type of adipocyte growth in other cases 
of obesity might be intriguing. Adipose tissue has 
depot specific characteristics. Differences are well 
known between visceral and subcutaneous fat, 
but subcutaneous adipocytes from abdominal and 
femoral region were also proved to have different 
signaling in adipogenesis (1). This kind of differ-
ences might hide the secret of the type of cells 
that are, under still unknown conditions, prone to 
proliferation and cause the singular body shape of 
MSL patients.
 The metabolic role of the lipomatous adipose 
tissue seems to differ from the metabolic burden 
of simple obesity. Although it cannot be general-
ized, some results indicate a decreased insulin 
resistance in MSL patients. The accumulation of 
subcutaneous fat leads to change in the subcu-
taneous to visceral fat content ratio, and this may 
reduce the insulin resistance analogous to the 
action of antidiabetic drugs like PPARγ agonists, 
thiazolidinediones. In this way, lipomatosis has 
been supposed to present a more benign mean of 
increasing energy stores. An audacious hypoth-
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esis on MSL as a paradigm of metabolically inno-
cent obesity has been proposed (8). 
 In conclusion, type 2 MSL with its characteristic 
distribution of fat deposits should first be remem-
bered on the differential diagnosis of obesity. In a 
wider context, revealing the secret of these sym-
metric lipomatous deposits would contribute to the 
expanding knowledge about the diverse roles of 
adipose tissue.
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